2012 | 2 | 303-305
Article title

Zastosowanie leków przeciwkrzepliwych u pacjentów z marskością wątroby − opis przypadku

Title variants
Languages of publication
  • Lisman T, Leebeek FWG. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences and treatment. Dig Surg 2007; 24(4): 250−258.
  • Lisman T, Caldwell SH, Leebeek FWG, et al. Hemostasis in chronic liver disease. J Thromb Haemost 2006; 4(4):717−720
  • Ragni MV. Liver disease, organ transplantation and hemostasis. In: Kitchens CS, Alving BM, Kessler CS, editors.Consultative hemostasis and thrombosis. Elsevier Science; 2002: 481−491.
  • Palester-Chlebowczyk M. Zaburzenia hemostazy w przebiegu marskości wątroby. Praca habilitacyjna. Warszawa:Akademia Medyczna; 1986.
  • Ponziani FR, Zocco MA, Tortora A, et al. Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? Exp Opin Pharmacother 2010; 11(9): 1479−1487.
  • Northup PG, Intagliata NM. Anticoagulation in cirrhosis patients: what don’t we know? Liver Int 2011; 31(1): 4−6.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.